company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,,2011-09-30,2011-11-03 17:26:52+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,72367000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,,2011-09-30,2011-11-03 17:26:52+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,4855000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,,2011-09-30,2011-11-03 17:26:52+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,4845000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,,2011-09-30,2011-11-03 17:26:52+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,82067000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,,2011-09-30,2011-11-03 17:26:52+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,14797000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,,2011-09-30,2011-11-03 17:26:52+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,484000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,,2011-09-30,2011-11-03 17:26:52+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,2428000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,,2011-09-30,2011-11-03 17:26:52+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,2912000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,,2011-09-30,2011-11-03 17:26:52+00:00,,totalassets,Total Assets,=,debit,usd,99776000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,,2011-09-30,2011-11-03 17:26:52+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,4350000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,,2011-09-30,2011-11-03 17:26:52+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4521000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,,2011-09-30,2011-11-03 17:26:52+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,10945000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,,2011-09-30,2011-11-03 17:26:52+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,65851000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,,2011-09-30,2011-11-03 17:26:52+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,7508000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,,2011-09-30,2011-11-03 17:26:52+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,93175000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,,2011-09-30,2011-11-03 17:26:52+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,88259000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,,2011-09-30,2011-11-03 17:26:52+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,51169000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,,2011-09-30,2011-11-03 17:26:52+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1010000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,,2011-09-30,2011-11-03 17:26:52+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,140438000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,,2011-09-30,2011-11-03 17:26:52+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,233613000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,,2011-09-30,2011-11-03 17:26:52+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,,2011-09-30,2011-11-03 17:26:52+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,347515000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,,2011-09-30,2011-11-03 17:26:52+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-550736000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,,2011-09-30,2011-11-03 17:26:52+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-1000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,,2011-09-30,2011-11-03 17:26:52+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,69385000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,,2011-09-30,2011-11-03 17:26:52+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-133837000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,,2011-09-30,2011-11-03 17:26:52+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-133837000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,,2011-09-30,2011-11-03 17:26:52+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-133837000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q1,,2011-09-30,2011-11-03 17:26:52+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,99776000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,,2011-12-31,2012-02-01 18:58:27+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,60363000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,,2011-12-31,2012-02-01 18:58:27+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,360000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,,2011-12-31,2012-02-01 18:58:27+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,4172000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,,2011-12-31,2012-02-01 18:58:27+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,64895000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,,2011-12-31,2012-02-01 18:58:27+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,13994000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,,2011-12-31,2012-02-01 18:58:27+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,554000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,,2011-12-31,2012-02-01 18:58:27+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,2709000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,,2011-12-31,2012-02-01 18:58:27+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,3263000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,,2011-12-31,2012-02-01 18:58:27+00:00,,totalassets,Total Assets,=,debit,usd,82152000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,,2011-12-31,2012-02-01 18:58:27+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,150000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,,2011-12-31,2012-02-01 18:58:27+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4948000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,,2011-12-31,2012-02-01 18:58:27+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,12292000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,,2011-12-31,2012-02-01 18:58:27+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,57879000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,,2011-12-31,2012-02-01 18:58:27+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,4759000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,,2011-12-31,2012-02-01 18:58:27+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,80028000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,,2011-12-31,2012-02-01 18:58:27+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,90036000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,,2011-12-31,2012-02-01 18:58:27+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,37993000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,,2011-12-31,2012-02-01 18:58:27+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1288000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,,2011-12-31,2012-02-01 18:58:27+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,129317000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,,2011-12-31,2012-02-01 18:58:27+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,209345000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,,2011-12-31,2012-02-01 18:58:27+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,,2011-12-31,2012-02-01 18:58:27+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,357964000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,,2011-12-31,2012-02-01 18:58:27+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-554542000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,,2011-12-31,2012-02-01 18:58:27+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,69385000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,,2011-12-31,2012-02-01 18:58:27+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-127193000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,,2011-12-31,2012-02-01 18:58:27+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-127193000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,,2011-12-31,2012-02-01 18:58:27+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-127193000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q2,,2011-12-31,2012-02-01 18:58:27+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,82152000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,,2012-03-31,2012-05-03 11:52:59+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,63025000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,,2012-03-31,2012-05-03 11:52:59+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,36411000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,,2012-03-31,2012-05-03 11:52:59+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,4680000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,,2012-03-31,2012-05-03 11:52:59+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,104116000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,,2012-03-31,2012-05-03 11:52:59+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,12931000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,,2012-03-31,2012-05-03 11:52:59+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,423000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,,2012-03-31,2012-05-03 11:52:59+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,2570000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,,2012-03-31,2012-05-03 11:52:59+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,2993000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,,2012-03-31,2012-05-03 11:52:59+00:00,,totalassets,Total Assets,=,debit,usd,120040000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,,2012-03-31,2012-05-03 11:52:59+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,150000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,,2012-03-31,2012-05-03 11:52:59+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4593000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,,2012-03-31,2012-05-03 11:52:59+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,14696000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,,2012-03-31,2012-05-03 11:52:59+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,50597000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,,2012-03-31,2012-05-03 11:52:59+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,5661000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,,2012-03-31,2012-05-03 11:52:59+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,75697000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,,2012-03-31,2012-05-03 11:52:59+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,90900000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,,2012-03-31,2012-05-03 11:52:59+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,31057000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,,2012-03-31,2012-05-03 11:52:59+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1156000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,,2012-03-31,2012-05-03 11:52:59+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,123113000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,,2012-03-31,2012-05-03 11:52:59+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,198810000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,,2012-03-31,2012-05-03 11:52:59+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,,2012-03-31,2012-05-03 11:52:59+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,428093000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,,2012-03-31,2012-05-03 11:52:59+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-562710000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,,2012-03-31,2012-05-03 11:52:59+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-1000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,,2012-03-31,2012-05-03 11:52:59+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,55848000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,,2012-03-31,2012-05-03 11:52:59+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-78770000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,,2012-03-31,2012-05-03 11:52:59+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-78770000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,,2012-03-31,2012-05-03 11:52:59+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-78770000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2012.0,Q3,,2012-03-31,2012-05-03 11:52:59+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,120040000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,,2012-09-30,2012-10-30 12:51:12+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,49054000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,,2012-09-30,2012-10-30 12:51:12+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,18279000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,,2012-09-30,2012-10-30 12:51:12+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3581000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,,2012-09-30,2012-10-30 12:51:12+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,70914000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,,2012-09-30,2012-10-30 12:51:12+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,11717000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,,2012-09-30,2012-10-30 12:51:12+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,542000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,,2012-09-30,2012-10-30 12:51:12+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,2318000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,,2012-09-30,2012-10-30 12:51:12+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,2860000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,,2012-09-30,2012-10-30 12:51:12+00:00,,totalassets,Total Assets,=,debit,usd,85491000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,,2012-09-30,2012-10-30 12:51:12+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,150000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,,2012-09-30,2012-10-30 12:51:12+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4309000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,,2012-09-30,2012-10-30 12:51:12+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,6403000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,,2012-09-30,2012-10-30 12:51:12+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,36635000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,,2012-09-30,2012-10-30 12:51:12+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,9172000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,,2012-09-30,2012-10-30 12:51:12+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,10098000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,,2012-09-30,2012-10-30 12:51:12+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,66767000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,,2012-09-30,2012-10-30 12:51:12+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,93178000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,,2012-09-30,2012-10-30 12:51:12+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,20894000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,,2012-09-30,2012-10-30 12:51:12+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1069000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,,2012-09-30,2012-10-30 12:51:12+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,115141000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,,2012-09-30,2012-10-30 12:51:12+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,181908000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,,2012-09-30,2012-10-30 12:51:12+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,,2012-09-30,2012-10-30 12:51:12+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,446703000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,,2012-09-30,2012-10-30 12:51:12+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-582505000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,,2012-09-30,2012-10-30 12:51:12+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,39385000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,,2012-09-30,2012-10-30 12:51:12+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-96417000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,,2012-09-30,2012-10-30 12:51:12+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-96417000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,,2012-09-30,2012-10-30 12:51:12+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-96417000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q1,,2012-09-30,2012-10-30 12:51:12+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,85491000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,,2012-12-31,2013-02-06 16:37:24+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,59565000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,,2012-12-31,2013-02-06 16:37:24+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,49616000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,,2012-12-31,2013-02-06 16:37:24+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,5098000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,,2012-12-31,2013-02-06 16:37:24+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,114279000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,,2012-12-31,2013-02-06 16:37:24+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,11245000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,,2012-12-31,2013-02-06 16:37:24+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,664000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,,2012-12-31,2013-02-06 16:37:24+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,2185000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,,2012-12-31,2013-02-06 16:37:24+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,2849000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,,2012-12-31,2013-02-06 16:37:24+00:00,,totalassets,Total Assets,=,debit,usd,128373000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,,2012-12-31,2013-02-06 16:37:24+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,,2012-12-31,2013-02-06 16:37:24+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4726000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,,2012-12-31,2013-02-06 16:37:24+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,6405000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,,2012-12-31,2013-02-06 16:37:24+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,30101000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,,2012-12-31,2013-02-06 16:37:24+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,5098000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,,2012-12-31,2013-02-06 16:37:24+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,3970000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,,2012-12-31,2013-02-06 16:37:24+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,50300000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,,2012-12-31,2013-02-06 16:37:24+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,94417000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,,2012-12-31,2013-02-06 16:37:24+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,14230000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,,2012-12-31,2013-02-06 16:37:24+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1143000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,,2012-12-31,2013-02-06 16:37:24+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,109790000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,,2012-12-31,2013-02-06 16:37:24+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,160090000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,,2012-12-31,2013-02-06 16:37:24+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,,2012-12-31,2013-02-06 16:37:24+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,,2012-12-31,2013-02-06 16:37:24+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,522331000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,,2012-12-31,2013-02-06 16:37:24+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-593435000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,,2012-12-31,2013-02-06 16:37:24+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,2000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,,2012-12-31,2013-02-06 16:37:24+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,39385000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,,2012-12-31,2013-02-06 16:37:24+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-31717000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,,2012-12-31,2013-02-06 16:37:24+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-31717000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,,2012-12-31,2013-02-06 16:37:24+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-31717000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q2,,2012-12-31,2013-02-06 16:37:24+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,128373000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,,2013-03-31,2013-05-07 17:16:05+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,43998000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,,2013-03-31,2013-05-07 17:16:05+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,42583000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,,2013-03-31,2013-05-07 17:16:05+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,7583000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,,2013-03-31,2013-05-07 17:16:05+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,94164000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,,2013-03-31,2013-05-07 17:16:05+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,10720000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,,2013-03-31,2013-05-07 17:16:05+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,466000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,,2013-03-31,2013-05-07 17:16:05+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,2081000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,,2013-03-31,2013-05-07 17:16:05+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,2547000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,,2013-03-31,2013-05-07 17:16:05+00:00,,totalassets,Total Assets,=,debit,usd,107431000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,,2013-03-31,2013-05-07 17:16:05+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,,2013-03-31,2013-05-07 17:16:05+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,7506000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,,2013-03-31,2013-05-07 17:16:05+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,6494000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,,2013-03-31,2013-05-07 17:16:05+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,25471000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,,2013-03-31,2013-05-07 17:16:05+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,7673000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,,2013-03-31,2013-05-07 17:16:05+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,6994000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,,2013-03-31,2013-05-07 17:16:05+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,54138000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,,2013-03-31,2013-05-07 17:16:05+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,95349000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,,2013-03-31,2013-05-07 17:16:05+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,9472000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,,2013-03-31,2013-05-07 17:16:05+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,887000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,,2013-03-31,2013-05-07 17:16:05+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,105708000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,,2013-03-31,2013-05-07 17:16:05+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,159846000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,,2013-03-31,2013-05-07 17:16:05+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,,2013-03-31,2013-05-07 17:16:05+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,,2013-03-31,2013-05-07 17:16:05+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,523226000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,,2013-03-31,2013-05-07 17:16:05+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-615028000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,,2013-03-31,2013-05-07 17:16:05+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,2000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,,2013-03-31,2013-05-07 17:16:05+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,39385000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,,2013-03-31,2013-05-07 17:16:05+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-52415000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,,2013-03-31,2013-05-07 17:16:05+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-52415000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,,2013-03-31,2013-05-07 17:16:05+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-52415000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2013.0,Q3,,2013-03-31,2013-05-07 17:16:05+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,107431000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,,2013-09-30,2013-11-01 16:20:38+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,65045000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,,2013-09-30,2013-11-01 16:20:38+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,58126000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,,2013-09-30,2013-11-01 16:20:38+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,1014000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,,2013-09-30,2013-11-01 16:20:38+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,9991000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,,2013-09-30,2013-11-01 16:20:38+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,134176000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,,2013-09-30,2013-11-01 16:20:38+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,9144000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,,2013-09-30,2013-11-01 16:20:38+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,550000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,,2013-09-30,2013-11-01 16:20:38+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,8775000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,,2013-09-30,2013-11-01 16:20:38+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,9325000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,,2013-09-30,2013-11-01 16:20:38+00:00,,totalassets,Total Assets,=,debit,usd,152645000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,,2013-09-30,2013-11-01 16:20:38+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3072000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,,2013-09-30,2013-11-01 16:20:38+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,8703000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,,2013-09-30,2013-11-01 16:20:38+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,17879000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,,2013-09-30,2013-11-01 16:20:38+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,10028000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,,2013-09-30,2013-11-01 16:20:38+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,12204000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,,2013-09-30,2013-11-01 16:20:38+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,51886000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,,2013-09-30,2013-11-01 16:20:38+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,100203000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,,2013-09-30,2013-11-01 16:20:38+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,13168000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,,2013-09-30,2013-11-01 16:20:38+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,550000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,,2013-09-30,2013-11-01 16:20:38+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,113921000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,,2013-09-30,2013-11-01 16:20:38+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,165807000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,,2013-09-30,2013-11-01 16:20:38+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,,2013-09-30,2013-11-01 16:20:38+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,,2013-09-30,2013-11-01 16:20:38+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,595804000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,,2013-09-30,2013-11-01 16:20:38+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-648359000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,,2013-09-30,2013-11-01 16:20:38+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,8000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,,2013-09-30,2013-11-01 16:20:38+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,39385000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,,2013-09-30,2013-11-01 16:20:38+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-13162000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,,2013-09-30,2013-11-01 16:20:38+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-13162000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,,2013-09-30,2013-11-01 16:20:38+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-13162000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q1,,2013-09-30,2013-11-01 16:20:38+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,152645000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,,2013-12-31,2014-02-05 16:56:04+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,47194000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,,2013-12-31,2014-02-05 16:56:04+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,72481000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,,2013-12-31,2014-02-05 16:56:04+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,5710000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,,2013-12-31,2014-02-05 16:56:04+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3088000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,,2013-12-31,2014-02-05 16:56:04+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,128473000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,,2013-12-31,2014-02-05 16:56:04+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,8421000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,,2013-12-31,2014-02-05 16:56:04+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,691000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,,2013-12-31,2014-02-05 16:56:04+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,8736000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,,2013-12-31,2014-02-05 16:56:04+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,9427000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,,2013-12-31,2014-02-05 16:56:04+00:00,,totalassets,Total Assets,=,debit,usd,146321000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,,2013-12-31,2014-02-05 16:56:04+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3958000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,,2013-12-31,2014-02-05 16:56:04+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,8989000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,,2013-12-31,2014-02-05 16:56:04+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,13227000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,,2013-12-31,2014-02-05 16:56:04+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,5414000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,,2013-12-31,2014-02-05 16:56:04+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,6690000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,,2013-12-31,2014-02-05 16:56:04+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,38278000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,,2013-12-31,2014-02-05 16:56:04+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,101430000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,,2013-12-31,2014-02-05 16:56:04+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,11272000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,,2013-12-31,2014-02-05 16:56:04+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,691000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,,2013-12-31,2014-02-05 16:56:04+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,113393000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,,2013-12-31,2014-02-05 16:56:04+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,151671000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,,2013-12-31,2014-02-05 16:56:04+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,,2013-12-31,2014-02-05 16:56:04+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,,2013-12-31,2014-02-05 16:56:04+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,620032000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,,2013-12-31,2014-02-05 16:56:04+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-664767000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,,2013-12-31,2014-02-05 16:56:04+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,,2013-12-31,2014-02-05 16:56:04+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,39385000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,,2013-12-31,2014-02-05 16:56:04+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-5350000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,,2013-12-31,2014-02-05 16:56:04+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-5350000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,,2013-12-31,2014-02-05 16:56:04+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-5350000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q2,,2013-12-31,2014-02-05 16:56:04+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,146321000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,,2014-03-31,2014-05-08 17:57:52+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,52178000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,,2014-03-31,2014-05-08 17:57:52+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,57714000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,,2014-03-31,2014-05-08 17:57:52+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,4433000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,,2014-03-31,2014-05-08 17:57:52+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3743000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,,2014-03-31,2014-05-08 17:57:52+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,118068000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,,2014-03-31,2014-05-08 17:57:52+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,7838000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,,2014-03-31,2014-05-08 17:57:52+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,593000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,,2014-03-31,2014-05-08 17:57:52+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,8656000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,,2014-03-31,2014-05-08 17:57:52+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,9249000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,,2014-03-31,2014-05-08 17:57:52+00:00,,totalassets,Total Assets,=,debit,usd,135155000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,,2014-03-31,2014-05-08 17:57:52+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,7020000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,,2014-03-31,2014-05-08 17:57:52+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,10206000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,,2014-03-31,2014-05-08 17:57:52+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,9450000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,,2014-03-31,2014-05-08 17:57:52+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,7221000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,,2014-03-31,2014-05-08 17:57:52+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,11967000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,,2014-03-31,2014-05-08 17:57:52+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,45864000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,,2014-03-31,2014-05-08 17:57:52+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,102675000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,,2014-03-31,2014-05-08 17:57:52+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,9361000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,,2014-03-31,2014-05-08 17:57:52+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,593000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,,2014-03-31,2014-05-08 17:57:52+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,112629000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,,2014-03-31,2014-05-08 17:57:52+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,158493000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,,2014-03-31,2014-05-08 17:57:52+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,,2014-03-31,2014-05-08 17:57:52+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,,2014-03-31,2014-05-08 17:57:52+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,626969000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,,2014-03-31,2014-05-08 17:57:52+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-689699000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,,2014-03-31,2014-05-08 17:57:52+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,7000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,,2014-03-31,2014-05-08 17:57:52+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,39385000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,,2014-03-31,2014-05-08 17:57:52+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-23338000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,,2014-03-31,2014-05-08 17:57:52+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-23338000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,,2014-03-31,2014-05-08 17:57:52+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-23338000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2014.0,Q3,,2014-03-31,2014-05-08 17:57:52+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,135155000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,,2014-09-30,2014-11-05 16:17:15+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,46829000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,,2014-09-30,2014-11-05 16:17:15+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,63873000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,,2014-09-30,2014-11-05 16:17:15+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,6000000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,,2014-09-30,2014-11-05 16:17:15+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,6085000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,,2014-09-30,2014-11-05 16:17:15+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,122787000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,,2014-09-30,2014-11-05 16:17:15+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,7764000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,,2014-09-30,2014-11-05 16:17:15+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,730000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,,2014-09-30,2014-11-05 16:17:15+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,4047000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,,2014-09-30,2014-11-05 16:17:15+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,4777000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,,2014-09-30,2014-11-05 16:17:15+00:00,,totalassets,Total Assets,=,debit,usd,135328000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,,2014-09-30,2014-11-05 16:17:15+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5216000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,,2014-09-30,2014-11-05 16:17:15+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,16836000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,,2014-09-30,2014-11-05 16:17:15+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,10145000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,,2014-09-30,2014-11-05 16:17:15+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,9419000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,,2014-09-30,2014-11-05 16:17:15+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,14953000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,,2014-09-30,2014-11-05 16:17:15+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,56569000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,,2014-09-30,2014-11-05 16:17:15+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,105263000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,,2014-09-30,2014-11-05 16:17:15+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,5650000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,,2014-09-30,2014-11-05 16:17:15+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,5426000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,,2014-09-30,2014-11-05 16:17:15+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,116339000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,,2014-09-30,2014-11-05 16:17:15+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,172908000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,,2014-09-30,2014-11-05 16:17:15+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,,2014-09-30,2014-11-05 16:17:15+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,,2014-09-30,2014-11-05 16:17:15+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,654042000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,,2014-09-30,2014-11-05 16:17:15+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-745529000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,,2014-09-30,2014-11-05 16:17:15+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,14522000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,,2014-09-30,2014-11-05 16:17:15+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,39385000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,,2014-09-30,2014-11-05 16:17:15+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-37580000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,,2014-09-30,2014-11-05 16:17:15+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-37580000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,,2014-09-30,2014-11-05 16:17:15+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-37580000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q1,,2014-09-30,2014-11-05 16:17:15+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,135328000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,,2014-12-31,2015-02-04 17:30:51+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,68145000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,,2014-12-31,2015-02-04 17:30:51+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,73416000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,,2014-12-31,2015-02-04 17:30:51+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,4878000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,,2014-12-31,2015-02-04 17:30:51+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,4315000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,,2014-12-31,2015-02-04 17:30:51+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,150754000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,,2014-12-31,2015-02-04 17:30:51+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,8072000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,,2014-12-31,2015-02-04 17:30:51+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,873000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,,2014-12-31,2015-02-04 17:30:51+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,3949000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,,2014-12-31,2015-02-04 17:30:51+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,4822000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,,2014-12-31,2015-02-04 17:30:51+00:00,,totalassets,Total Assets,=,debit,usd,163648000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,,2014-12-31,2015-02-04 17:30:51+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,9264000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,,2014-12-31,2015-02-04 17:30:51+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,16897000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,,2014-12-31,2015-02-04 17:30:51+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,11849000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,,2014-12-31,2015-02-04 17:30:51+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,4910000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,,2014-12-31,2015-02-04 17:30:51+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,25019000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,,2014-12-31,2015-02-04 17:30:51+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,67939000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,,2014-12-31,2015-02-04 17:30:51+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,106607000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,,2014-12-31,2015-02-04 17:30:51+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,2156000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,,2014-12-31,2015-02-04 17:30:51+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,873000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,,2014-12-31,2015-02-04 17:30:51+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,109636000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,,2014-12-31,2015-02-04 17:30:51+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,177575000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,,2014-12-31,2015-02-04 17:30:51+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,,2014-12-31,2015-02-04 17:30:51+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,,2014-12-31,2015-02-04 17:30:51+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,687365000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,,2014-12-31,2015-02-04 17:30:51+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-754140000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,,2014-12-31,2015-02-04 17:30:51+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,13463000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,,2014-12-31,2015-02-04 17:30:51+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,39385000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,,2014-12-31,2015-02-04 17:30:51+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-13927000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,,2014-12-31,2015-02-04 17:30:51+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-13927000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,,2014-12-31,2015-02-04 17:30:51+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-13927000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q2,,2014-12-31,2015-02-04 17:30:51+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,163648000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,,2015-03-31,2015-05-06 21:50:48+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,141470000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,,2015-03-31,2015-05-06 21:50:48+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,48600000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,,2015-03-31,2015-05-06 21:50:48+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,2116000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,,2015-03-31,2015-05-06 21:50:48+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,4409000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,,2015-03-31,2015-05-06 21:50:48+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,196595000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,,2015-03-31,2015-05-06 21:50:48+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,7455000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,,2015-03-31,2015-05-06 21:50:48+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,546000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,,2015-03-31,2015-05-06 21:50:48+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,3849000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,,2015-03-31,2015-05-06 21:50:48+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,4395000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,,2015-03-31,2015-05-06 21:50:48+00:00,,totalassets,Total Assets,=,debit,usd,208445000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,,2015-03-31,2015-05-06 21:50:48+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,7616000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,,2015-03-31,2015-05-06 21:50:48+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,16970000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,,2015-03-31,2015-05-06 21:50:48+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,13654000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,,2015-03-31,2015-05-06 21:50:48+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,6677000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,,2015-03-31,2015-05-06 21:50:48+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,,2015-03-31,2015-05-06 21:50:48+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,44917000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,,2015-03-31,2015-05-06 21:50:48+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,107985000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,,2015-03-31,2015-05-06 21:50:48+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,4846000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,,2015-03-31,2015-05-06 21:50:48+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,546000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,,2015-03-31,2015-05-06 21:50:48+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,113377000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,,2015-03-31,2015-05-06 21:50:48+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,158294000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,,2015-03-31,2015-05-06 21:50:48+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,,2015-03-31,2015-05-06 21:50:48+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,,2015-03-31,2015-05-06 21:50:48+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,696801000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,,2015-03-31,2015-05-06 21:50:48+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-695833000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,,2015-03-31,2015-05-06 21:50:48+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,9798000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,,2015-03-31,2015-05-06 21:50:48+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,39385000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,,2015-03-31,2015-05-06 21:50:48+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,50151000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,,2015-03-31,2015-05-06 21:50:48+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,50151000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,,2015-03-31,2015-05-06 21:50:48+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,50151000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2015.0,Q3,,2015-03-31,2015-05-06 21:50:48+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,208445000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,,2015-09-30,2015-11-05 18:19:02+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,56358000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,,2015-09-30,2015-11-05 18:19:02+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,102944000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,,2015-09-30,2015-11-05 18:19:02+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,13504000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,,2015-09-30,2015-11-05 18:19:02+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,6797000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,,2015-09-30,2015-11-05 18:19:02+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,179603000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,,2015-09-30,2015-11-05 18:19:02+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,4988000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,,2015-09-30,2015-11-05 18:19:02+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,514000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,,2015-09-30,2015-11-05 18:19:02+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1647000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,,2015-09-30,2015-11-05 18:19:02+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,2161000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,,2015-09-30,2015-11-05 18:19:02+00:00,,totalassets,Total Assets,=,debit,usd,186752000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,,2015-09-30,2015-11-05 18:19:02+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,6478000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,,2015-09-30,2015-11-05 18:19:02+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,21208000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,,2015-09-30,2015-11-05 18:19:02+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,12811000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,,2015-09-30,2015-11-05 18:19:02+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,8764000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,,2015-09-30,2015-11-05 18:19:02+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,49261000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,,2015-09-30,2015-11-05 18:19:02+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,108813000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,,2015-09-30,2015-11-05 18:19:02+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,4063000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,,2015-09-30,2015-11-05 18:19:02+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,514000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,,2015-09-30,2015-11-05 18:19:02+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,113390000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,,2015-09-30,2015-11-05 18:19:02+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,162651000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,,2015-09-30,2015-11-05 18:19:02+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,,2015-09-30,2015-11-05 18:19:02+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,,2015-09-30,2015-11-05 18:19:02+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,753638000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,,2015-09-30,2015-11-05 18:19:02+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-729554000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,,2015-09-30,2015-11-05 18:19:02+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,17000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,,2015-09-30,2015-11-05 18:19:02+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,24101000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,,2015-09-30,2015-11-05 18:19:02+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,24101000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,,2015-09-30,2015-11-05 18:19:02+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,24101000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q1,,2015-09-30,2015-11-05 18:19:02+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,186752000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,,2015-12-31,2016-02-05 16:10:05+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,57253000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,,2015-12-31,2016-02-05 16:10:05+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,62631000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,,2015-12-31,2016-02-05 16:10:05+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,64782000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,,2015-12-31,2016-02-05 16:10:05+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,7216000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,,2015-12-31,2016-02-05 16:10:05+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,191882000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,,2015-12-31,2016-02-05 16:10:05+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,5694000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,,2015-12-31,2016-02-05 16:10:05+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,705000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,,2015-12-31,2016-02-05 16:10:05+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1637000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,,2015-12-31,2016-02-05 16:10:05+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,2342000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,,2015-12-31,2016-02-05 16:10:05+00:00,,totalassets,Total Assets,=,debit,usd,199918000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,,2015-12-31,2016-02-05 16:10:05+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,12110000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,,2015-12-31,2016-02-05 16:10:05+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,22747000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,,2015-12-31,2016-02-05 16:10:05+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,12528000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,,2015-12-31,2016-02-05 16:10:05+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,5635000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,,2015-12-31,2016-02-05 16:10:05+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,53020000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,,2015-12-31,2016-02-05 16:10:05+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,110386000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,,2015-12-31,2016-02-05 16:10:05+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,29933000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,,2015-12-31,2016-02-05 16:10:05+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,705000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,,2015-12-31,2016-02-05 16:10:05+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,141024000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,,2015-12-31,2016-02-05 16:10:05+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,194044000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,,2015-12-31,2016-02-05 16:10:05+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,,2015-12-31,2016-02-05 16:10:05+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,,2015-12-31,2016-02-05 16:10:05+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,759629000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,,2015-12-31,2016-02-05 16:10:05+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-753718000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,,2015-12-31,2016-02-05 16:10:05+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-37000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,,2015-12-31,2016-02-05 16:10:05+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,5874000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,,2015-12-31,2016-02-05 16:10:05+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,5874000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,,2015-12-31,2016-02-05 16:10:05+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,5874000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q2,,2015-12-31,2016-02-05 16:10:05+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,199918000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,,2016-03-31,2016-05-04 17:26:18+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,62458000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,,2016-03-31,2016-05-04 17:26:18+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,55398000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,,2016-03-31,2016-05-04 17:26:18+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,62921000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,,2016-03-31,2016-05-04 17:26:18+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,6748000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,,2016-03-31,2016-05-04 17:26:18+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,187525000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,,2016-03-31,2016-05-04 17:26:18+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,6498000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,,2016-03-31,2016-05-04 17:26:18+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,540000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,,2016-03-31,2016-05-04 17:26:18+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1621000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,,2016-03-31,2016-05-04 17:26:18+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,2161000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,,2016-03-31,2016-05-04 17:26:18+00:00,,totalassets,Total Assets,=,debit,usd,196184000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,,2016-03-31,2016-05-04 17:26:18+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,15568000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,,2016-03-31,2016-05-04 17:26:18+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,25578000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,,2016-03-31,2016-05-04 17:26:18+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,11621000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,,2016-03-31,2016-05-04 17:26:18+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,6713000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,,2016-03-31,2016-05-04 17:26:18+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,59480000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,,2016-03-31,2016-05-04 17:26:18+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,111999000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,,2016-03-31,2016-05-04 17:26:18+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,38968000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,,2016-03-31,2016-05-04 17:26:18+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,540000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,,2016-03-31,2016-05-04 17:26:18+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,151507000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,,2016-03-31,2016-05-04 17:26:18+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,210987000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,,2016-03-31,2016-05-04 17:26:18+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,,2016-03-31,2016-05-04 17:26:18+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,,2016-03-31,2016-05-04 17:26:18+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,761576000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,,2016-03-31,2016-05-04 17:26:18+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-776393000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,,2016-03-31,2016-05-04 17:26:18+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,14000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,,2016-03-31,2016-05-04 17:26:18+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-14803000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,,2016-03-31,2016-05-04 17:26:18+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-14803000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,,2016-03-31,2016-05-04 17:26:18+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-14803000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2016.0,Q3,,2016-03-31,2016-05-04 17:26:18+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,196184000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q1,,2016-09-30,2016-11-03 08:36:26+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,65842000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q1,,2016-09-30,2016-11-03 08:36:26+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,50810000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q1,,2016-09-30,2016-11-03 08:36:26+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,33938000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q1,,2016-09-30,2016-11-03 08:36:26+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,7429000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q1,,2016-09-30,2016-11-03 08:36:26+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,158019000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q1,,2016-09-30,2016-11-03 08:36:26+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,7251000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q1,,2016-09-30,2016-11-03 08:36:26+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,662000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q1,,2016-09-30,2016-11-03 08:36:26+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,929000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q1,,2016-09-30,2016-11-03 08:36:26+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1591000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q1,,2016-09-30,2016-11-03 08:36:26+00:00,,totalassets,Total Assets,=,debit,usd,166861000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q1,,2016-09-30,2016-11-03 08:36:26+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,10200000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q1,,2016-09-30,2016-11-03 08:36:26+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5921000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q1,,2016-09-30,2016-11-03 08:36:26+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,27496000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q1,,2016-09-30,2016-11-03 08:36:26+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,10442000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q1,,2016-09-30,2016-11-03 08:36:26+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,10154000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q1,,2016-09-30,2016-11-03 08:36:26+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,64213000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q1,,2016-09-30,2016-11-03 08:36:26+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,115353000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q1,,2016-09-30,2016-11-03 08:36:26+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,38757000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q1,,2016-09-30,2016-11-03 08:36:26+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,662000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q1,,2016-09-30,2016-11-03 08:36:26+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,154772000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q1,,2016-09-30,2016-11-03 08:36:26+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,218985000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q1,,2016-09-30,2016-11-03 08:36:26+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q1,,2016-09-30,2016-11-03 08:36:26+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q1,,2016-09-30,2016-11-03 08:36:26+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,777880000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q1,,2016-09-30,2016-11-03 08:36:26+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-830000000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q1,,2016-09-30,2016-11-03 08:36:26+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,11000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q1,,2016-09-30,2016-11-03 08:36:26+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,-52109000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q1,,2016-09-30,2016-11-03 08:36:26+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,-52124000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q1,,2016-09-30,2016-11-03 08:36:26+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,-52124000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q1,,2016-09-30,2016-11-03 08:36:26+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,166861000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q2,,2016-12-31,2017-02-09 08:11:28+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,62785000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q2,,2016-12-31,2017-02-09 08:11:28+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,151147000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q2,,2016-12-31,2017-02-09 08:11:28+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,43122000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q2,,2016-12-31,2017-02-09 08:11:28+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,6835000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q2,,2016-12-31,2017-02-09 08:11:28+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,263889000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q2,,2016-12-31,2017-02-09 08:11:28+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,7442000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q2,,2016-12-31,2017-02-09 08:11:28+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,822000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q2,,2016-12-31,2017-02-09 08:11:28+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,49000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q2,,2016-12-31,2017-02-09 08:11:28+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,871000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q2,,2016-12-31,2017-02-09 08:11:28+00:00,,totalassets,Total Assets,=,debit,usd,272202000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q2,,2016-12-31,2017-02-09 08:11:28+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,10800000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q2,,2016-12-31,2017-02-09 08:11:28+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,6454000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q2,,2016-12-31,2017-02-09 08:11:28+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,30220000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q2,,2016-12-31,2017-02-09 08:11:28+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,11522000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q2,,2016-12-31,2017-02-09 08:11:28+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,5389000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q2,,2016-12-31,2017-02-09 08:11:28+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,64385000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q2,,2016-12-31,2017-02-09 08:11:28+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,117544000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q2,,2016-12-31,2017-02-09 08:11:28+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,37399000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q2,,2016-12-31,2017-02-09 08:11:28+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,822000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q2,,2016-12-31,2017-02-09 08:11:28+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,155765000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q2,,2016-12-31,2017-02-09 08:11:28+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,220150000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q2,,2016-12-31,2017-02-09 08:11:28+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q2,,2016-12-31,2017-02-09 08:11:28+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q2,,2016-12-31,2017-02-09 08:11:28+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,905418000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q2,,2016-12-31,2017-02-09 08:11:28+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-853316000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q2,,2016-12-31,2017-02-09 08:11:28+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-50000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q2,,2016-12-31,2017-02-09 08:11:28+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,52052000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q2,,2016-12-31,2017-02-09 08:11:28+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,52052000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q2,,2016-12-31,2017-02-09 08:11:28+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,52052000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q2,,2016-12-31,2017-02-09 08:11:28+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,272202000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q3,,2017-03-31,2017-05-10 08:04:07+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,83749000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q3,,2017-03-31,2017-05-10 08:04:07+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,122996000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q3,,2017-03-31,2017-05-10 08:04:07+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,32507000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q3,,2017-03-31,2017-05-10 08:04:07+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,7699000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q3,,2017-03-31,2017-05-10 08:04:07+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,246951000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q3,,2017-03-31,2017-05-10 08:04:07+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,8488000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q3,,2017-03-31,2017-05-10 08:04:07+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,647000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q3,,2017-03-31,2017-05-10 08:04:07+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,116000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q3,,2017-03-31,2017-05-10 08:04:07+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,763000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q3,,2017-03-31,2017-05-10 08:04:07+00:00,,totalassets,Total Assets,=,debit,usd,256202000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q3,,2017-03-31,2017-05-10 08:04:07+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,12100000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q3,,2017-03-31,2017-05-10 08:04:07+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,7758000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q3,,2017-03-31,2017-05-10 08:04:07+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,32981000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q3,,2017-03-31,2017-05-10 08:04:07+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,10974000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q3,,2017-03-31,2017-05-10 08:04:07+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,7437000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q3,,2017-03-31,2017-05-10 08:04:07+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,71250000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q3,,2017-03-31,2017-05-10 08:04:07+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,119394000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q3,,2017-03-31,2017-05-10 08:04:07+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,37060000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q3,,2017-03-31,2017-05-10 08:04:07+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,784000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q3,,2017-03-31,2017-05-10 08:04:07+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,157238000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q3,,2017-03-31,2017-05-10 08:04:07+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,228488000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q3,,2017-03-31,2017-05-10 08:04:07+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q3,,2017-03-31,2017-05-10 08:04:07+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q3,,2017-03-31,2017-05-10 08:04:07+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,916869000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q3,,2017-03-31,2017-05-10 08:04:07+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-889069000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q3,,2017-03-31,2017-05-10 08:04:07+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-86000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q3,,2017-03-31,2017-05-10 08:04:07+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,27714000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q3,,2017-03-31,2017-05-10 08:04:07+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,27714000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q3,,2017-03-31,2017-05-10 08:04:07+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,27714000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2017.0,Q3,,2017-03-31,2017-05-10 08:04:07+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,256202000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,,2017-09-30,2017-10-31 09:22:40+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,295414000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,,2017-09-30,2017-10-31 09:22:40+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,168093000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,,2017-09-30,2017-10-31 09:22:40+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,26601000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,,2017-09-30,2017-10-31 09:22:40+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3716000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,,2017-09-30,2017-10-31 09:22:40+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,493824000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,,2017-09-30,2017-10-31 09:22:40+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,7579000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,,2017-09-30,2017-10-31 09:22:40+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,829000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,,2017-09-30,2017-10-31 09:22:40+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,77000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,,2017-09-30,2017-10-31 09:22:40+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,906000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,,2017-09-30,2017-10-31 09:22:40+00:00,,totalassets,Total Assets,=,debit,usd,502309000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,,2017-09-30,2017-10-31 09:22:40+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,12400000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,,2017-09-30,2017-10-31 09:22:40+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,8881000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,,2017-09-30,2017-10-31 09:22:40+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,40150000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,,2017-09-30,2017-10-31 09:22:40+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,17309000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,,2017-09-30,2017-10-31 09:22:40+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,12185000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,,2017-09-30,2017-10-31 09:22:40+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,90925000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,,2017-09-30,2017-10-31 09:22:40+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,123266000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,,2017-09-30,2017-10-31 09:22:40+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,60496000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,,2017-09-30,2017-10-31 09:22:40+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1001000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,,2017-09-30,2017-10-31 09:22:40+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,184763000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,,2017-09-30,2017-10-31 09:22:40+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,275688000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,,2017-09-30,2017-10-31 09:22:40+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,,2017-09-30,2017-10-31 09:22:40+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,,2017-09-30,2017-10-31 09:22:40+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1183318000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,,2017-09-30,2017-10-31 09:22:40+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-956700000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,,2017-09-30,2017-10-31 09:22:40+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-42000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,,2017-09-30,2017-10-31 09:22:40+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,226576000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,,2017-09-30,2017-10-31 09:22:40+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,226621000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,,2017-09-30,2017-10-31 09:22:40+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,226621000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q1,,2017-09-30,2017-10-31 09:22:40+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,502309000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q2,,2017-12-31,2018-02-06 08:11:44+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,65051000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q2,,2017-12-31,2018-02-06 08:11:44+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,354221000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q2,,2017-12-31,2018-02-06 08:11:44+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,29970000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q2,,2017-12-31,2018-02-06 08:11:44+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,4614000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q2,,2017-12-31,2018-02-06 08:11:44+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,453856000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q2,,2017-12-31,2018-02-06 08:11:44+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,7206000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q2,,2017-12-31,2018-02-06 08:11:44+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,1045000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q2,,2017-12-31,2018-02-06 08:11:44+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,738000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q2,,2017-12-31,2018-02-06 08:11:44+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1783000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q2,,2017-12-31,2018-02-06 08:11:44+00:00,,totalassets,Total Assets,=,debit,usd,462845000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q2,,2017-12-31,2018-02-06 08:11:44+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,12700000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q2,,2017-12-31,2018-02-06 08:11:44+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,10996000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q2,,2017-12-31,2018-02-06 08:11:44+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,29055000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q2,,2017-12-31,2018-02-06 08:11:44+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,14090000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q2,,2017-12-31,2018-02-06 08:11:44+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,6772000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q2,,2017-12-31,2018-02-06 08:11:44+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,73613000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q2,,2017-12-31,2018-02-06 08:11:44+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,93264000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q2,,2017-12-31,2018-02-06 08:11:44+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,52587000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q2,,2017-12-31,2018-02-06 08:11:44+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1199000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q2,,2017-12-31,2018-02-06 08:11:44+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,147050000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q2,,2017-12-31,2018-02-06 08:11:44+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,220663000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q2,,2017-12-31,2018-02-06 08:11:44+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q2,,2017-12-31,2018-02-06 08:11:44+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q2,,2017-12-31,2018-02-06 08:11:44+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1233566000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q2,,2017-12-31,2018-02-06 08:11:44+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-990708000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q2,,2017-12-31,2018-02-06 08:11:44+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-676000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q2,,2017-12-31,2018-02-06 08:11:44+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,242182000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q2,,2017-12-31,2018-02-06 08:11:44+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,242182000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q2,,2017-12-31,2018-02-06 08:11:44+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,242182000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q2,,2017-12-31,2018-02-06 08:11:44+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,462845000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q3,,2018-03-31,2018-05-09 08:14:48+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,73855000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q3,,2018-03-31,2018-05-09 08:14:48+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,364555000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q3,,2018-03-31,2018-05-09 08:14:48+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,44158000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q3,,2018-03-31,2018-05-09 08:14:48+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,5222000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q3,,2018-03-31,2018-05-09 08:14:48+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,487790000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q3,,2018-03-31,2018-05-09 08:14:48+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,7554000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q3,,2018-03-31,2018-05-09 08:14:48+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,1108000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q3,,2018-03-31,2018-05-09 08:14:48+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,555000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q3,,2018-03-31,2018-05-09 08:14:48+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1663000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q3,,2018-03-31,2018-05-09 08:14:48+00:00,,totalassets,Total Assets,=,debit,usd,497007000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q3,,2018-03-31,2018-05-09 08:14:48+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,12800000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q3,,2018-03-31,2018-05-09 08:14:48+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,11723000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q3,,2018-03-31,2018-05-09 08:14:48+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,37113000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q3,,2018-03-31,2018-05-09 08:14:48+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,13108000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q3,,2018-03-31,2018-05-09 08:14:48+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,10345000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q3,,2018-03-31,2018-05-09 08:14:48+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,85089000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q3,,2018-03-31,2018-05-09 08:14:48+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,94555000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q3,,2018-03-31,2018-05-09 08:14:48+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,50728000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q3,,2018-03-31,2018-05-09 08:14:48+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1485000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q3,,2018-03-31,2018-05-09 08:14:48+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,146768000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q3,,2018-03-31,2018-05-09 08:14:48+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,231857000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q3,,2018-03-31,2018-05-09 08:14:48+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q3,,2018-03-31,2018-05-09 08:14:48+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q3,,2018-03-31,2018-05-09 08:14:48+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1279466000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q3,,2018-03-31,2018-05-09 08:14:48+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1013559000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q3,,2018-03-31,2018-05-09 08:14:48+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-757000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q3,,2018-03-31,2018-05-09 08:14:48+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,265150000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q3,,2018-03-31,2018-05-09 08:14:48+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,265150000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q3,,2018-03-31,2018-05-09 08:14:48+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,265150000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2018.0,Q3,,2018-03-31,2018-05-09 08:14:48+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,497007000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,,2018-09-30,2018-10-30 08:08:34+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,130507000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,,2018-09-30,2018-10-30 08:08:34+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,283886000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,,2018-09-30,2018-10-30 08:08:34+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,44378000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,,2018-09-30,2018-10-30 08:08:34+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,17439000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,,2018-09-30,2018-10-30 08:08:34+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,476210000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,,2018-09-30,2018-10-30 08:08:34+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,6860000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,,2018-09-30,2018-10-30 08:08:34+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,998000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,,2018-09-30,2018-10-30 08:08:34+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,151000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,,2018-09-30,2018-10-30 08:08:34+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1149000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,,2018-09-30,2018-10-30 08:08:34+00:00,,totalassets,Total Assets,=,debit,usd,484219000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,,2018-09-30,2018-10-30 08:08:34+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,,2018-09-30,2018-10-30 08:08:34+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,14609000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,,2018-09-30,2018-10-30 08:08:34+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,40814000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,,2018-09-30,2018-10-30 08:08:34+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,12149000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,,2018-09-30,2018-10-30 08:08:34+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,17194000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,,2018-09-30,2018-10-30 08:08:34+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,84766000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,,2018-09-30,2018-10-30 08:08:34+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,131093000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,,2018-09-30,2018-10-30 08:08:34+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,48049000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,,2018-09-30,2018-10-30 08:08:34+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1243000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,,2018-09-30,2018-10-30 08:08:34+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,180385000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,,2018-09-30,2018-10-30 08:08:34+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,265151000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,,2018-09-30,2018-10-30 08:08:34+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,,2018-09-30,2018-10-30 08:08:34+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,,2018-09-30,2018-10-30 08:08:34+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1310198000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,,2018-09-30,2018-10-30 08:08:34+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1090818000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,,2018-09-30,2018-10-30 08:08:34+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-312000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,,2018-09-30,2018-10-30 08:08:34+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,219068000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,,2018-09-30,2018-10-30 08:08:34+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,219068000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,,2018-09-30,2018-10-30 08:08:34+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,219068000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q1,,2018-09-30,2018-10-30 08:08:34+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,484219000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q2,,2018-12-31,2019-02-05 08:07:03+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,147094000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q2,,2018-12-31,2019-02-05 08:07:03+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,329964000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q2,,2018-12-31,2019-02-05 08:07:03+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,22245000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q2,,2018-12-31,2019-02-05 08:07:03+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,31537000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q2,,2018-12-31,2019-02-05 08:07:03+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,530840000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q2,,2018-12-31,2019-02-05 08:07:03+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,6902000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q2,,2018-12-31,2019-02-05 08:07:03+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,1095000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q2,,2018-12-31,2019-02-05 08:07:03+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,10125000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q2,,2018-12-31,2019-02-05 08:07:03+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,11220000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q2,,2018-12-31,2019-02-05 08:07:03+00:00,,totalassets,Total Assets,=,debit,usd,548962000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q2,,2018-12-31,2019-02-05 08:07:03+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q2,,2018-12-31,2019-02-05 08:07:03+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,10420000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q2,,2018-12-31,2019-02-05 08:07:03+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,46174000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q2,,2018-12-31,2019-02-05 08:07:03+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,13486000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q2,,2018-12-31,2019-02-05 08:07:03+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,14105000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q2,,2018-12-31,2019-02-05 08:07:03+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,84185000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q2,,2018-12-31,2019-02-05 08:07:03+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,132654000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q2,,2018-12-31,2019-02-05 08:07:03+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,45483000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q2,,2018-12-31,2019-02-05 08:07:03+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1289000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q2,,2018-12-31,2019-02-05 08:07:03+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,179426000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q2,,2018-12-31,2019-02-05 08:07:03+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,263611000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q2,,2018-12-31,2019-02-05 08:07:03+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q2,,2018-12-31,2019-02-05 08:07:03+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q2,,2018-12-31,2019-02-05 08:07:03+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1387640000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q2,,2018-12-31,2019-02-05 08:07:03+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1102180000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q2,,2018-12-31,2019-02-05 08:07:03+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-109000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q2,,2018-12-31,2019-02-05 08:07:03+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,285351000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q2,,2018-12-31,2019-02-05 08:07:03+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,285351000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q2,,2018-12-31,2019-02-05 08:07:03+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,285351000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q2,,2018-12-31,2019-02-05 08:07:03+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,548962000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,,2019-03-31,2019-05-07 08:14:58+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,96636000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,,2019-03-31,2019-05-07 08:14:58+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,326452000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,,2019-03-31,2019-05-07 08:14:58+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,31660000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,,2019-03-31,2019-05-07 08:14:58+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,4397000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,,2019-03-31,2019-05-07 08:14:58+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,34769000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,,2019-03-31,2019-05-07 08:14:58+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,493914000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,,2019-03-31,2019-05-07 08:14:58+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,6977000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,,2019-03-31,2019-05-07 08:14:58+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,56008000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,,2019-03-31,2019-05-07 08:14:58+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,10105000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,,2019-03-31,2019-05-07 08:14:58+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,66113000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,,2019-03-31,2019-05-07 08:14:58+00:00,,totalassets,Total Assets,=,debit,usd,567004000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,,2019-03-31,2019-05-07 08:14:58+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,,2019-03-31,2019-05-07 08:14:58+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,9128000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,,2019-03-31,2019-05-07 08:14:58+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,46678000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,,2019-03-31,2019-05-07 08:14:58+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,14410000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,,2019-03-31,2019-05-07 08:14:58+00:00,totalcurrentliabilities,currentemployeebenefitliabilities,Current Employee Benefit Liabilities,+,credit,usd,16444000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,,2019-03-31,2019-05-07 08:14:58+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,86660000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,,2019-03-31,2019-05-07 08:14:58+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,134245000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,,2019-03-31,2019-05-07 08:14:58+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,43528000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,,2019-03-31,2019-05-07 08:14:58+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,946000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,,2019-03-31,2019-05-07 08:14:58+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,178719000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,,2019-03-31,2019-05-07 08:14:58+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,265379000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,,2019-03-31,2019-05-07 08:14:58+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,,2019-03-31,2019-05-07 08:14:58+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,,2019-03-31,2019-05-07 08:14:58+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1441134000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,,2019-03-31,2019-05-07 08:14:58+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1139674000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,,2019-03-31,2019-05-07 08:14:58+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,165000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,,2019-03-31,2019-05-07 08:14:58+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,301625000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,,2019-03-31,2019-05-07 08:14:58+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,301625000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,,2019-03-31,2019-05-07 08:14:58+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,301625000.0
Array Biopharma Inc,ARRY,5493005R5EYH03HUKO92,0001100412,2019.0,Q3,,2019-03-31,2019-05-07 08:14:58+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,567004000.0
